Pain RSS Page 7

Filtered By:
Vaccination: Malaria Vaccine

This page shows you your search results in order of date. This is page number 7.

Order by Relevance | Date

Total 97 results found since Jan 2013.

Preparing for a dengue fever vaccine: why Brazil's ahead of the game
Six dengue vaccine candidates are in various stages of clinical development but developing countries will not receive the benefits if planning does not start nowDengue fever is now endemic in more that 125 countries. Six vaccines are currently in clinical development and policymakers and global health leaders need to be ready for when they come on the market.The World Health Organisation (WHO) has called dengue fever the fastest spreading vector-borne viral disease with "epidemic potential" and "staggering" consequences. In the past 50 years, the number of reported cases has increased 30-fold. While the WHO estimates that ...
Source: Guardian Unlimited Science - January 27, 2014 Category: Science Tags: Guardian Professional Infectious diseases Malaria and infectious diseases Health Medical research Vietnam Microbiology Vaccines and immunisation Brazil Society Immunology Editorial Global development professionals network World H Source Type: news

The Behind the Headlines 2013's Top Five of Top Fives
As we move towards the end of the year, like all news sources, we fall back on that classic space filler – the list story. So without further ado, here is the official Behind the Headlines Top Five of Top Fives stories of 2013. The top five "Good work team!" stories of the year We can often get bogged down in pointing out dodgy sub-group analyses, spurious extrapolations of samples sizes containing just four men and a dog, and RCTs pointing out the benefits of chocolate on blood pressure that turned out to be funded by a chocolate-making conglomerate. So it's important not to lose sight of the fact that ther...
Source: NHS News Feed - December 31, 2013 Category: Consumer Health News Tags: QA articles Medical practice Source Type: news

NIH and Other Public Private Partnerships to Research Treatments for Multiple Diseases
Over the past few weeks, the National Institutes of Health (NIH) has made a number of important announcements regarding collaborations with industry as well as the funding of several new research initiatives. Below is a summary of these stories. NIH Partners With Eli Lilly and Others on Rare Diseases FierceBiotechResearch reported that NIH selected four (4) new preclinical drug development studies to uncover new therapies for rare diseases. The projects will be funded through the Therapeutics for Rare and Neglected Diseases (TRND) program under NIH's National Center for Advancing Translational Sciences, NCATS, which ...
Source: Policy and Medicine - October 4, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs

Twerking Disease: The Definitive Medical Resource For Doctors.
This study was published in Time magazine so it must be true. In addition, the story was picked up by 95.8 THE BONE and was described by a self proclaimed expert twerker jockey between songs about booty slappin' and G-thangs. EXERCISE Studies have shown most folks watching Richard Simmons in "Twerking to the Oldies" have been cured of their twerking addiction. MIRROR THERAPY Consider buying a full length wall mirror for full therapeutic effect. Alternatively, take a video of yourself twerking while checking yourself out in a mirror, put it on YouTube and let ever...
Source: The Happy Hospitalist - September 7, 2013 Category: Internists and Doctors of Medicine Authors: Tamer Mahrous Source Type: blogs

PhRMA Report: Over 5400 Medicines in Development and 70% are First in Class
According to report released by PhRMA, companies have more than 5,400 medicines in development globally, and more than 70% of therapies in the pipeline are potentially first-in-class and could offer patients new treatment options, and a notable number of potential therapies target diseases with limited treatment options such as ALS and rare diseases. A breakdown of their report offers insight into the various medicines in development for different diseases and populations. Older Americans America’s biopharmaceutical research companies are developing 465 new medicines that target the 10 leading chronic conditi...
Source: Policy and Medicine - April 24, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs

Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01
Results of a Phase I MSP-1 vaccine trial in healthy malaria-na¿ve adults in the US and in malaria-experienced adults in Kenya. The vaccine was well tolerated, although many vaccine recipients experienced pain, and several had local and systemic symptoms after vaccination; this is consistent with other AS01 adjuvanted vaccines.
Source: Malaria Journal - January 23, 2013 Category: Infectious Diseases Authors: Nekoye OtsyulaEvelina AngovElke Bergmann-LeitnerMargaret KoechFarhat KhanJason BennettLucas OtienoJames CummingsBen AndagaluDonna ToshJohn WaitumbiNancy RichieMeng ShiLori MillerWalter OtienoGodfrey OtienoLisa WareBrent HouseOlivier GodeauxMarie-Claude Du Source Type: research

Pages: 1 2 3 4 5 6 7